Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Bayer AG

Start price
Target price
Perf. (%)
€57.80
18.03.22
-
18.03.23
4.83%
25.03.22

Mori8 
18.03.22 50%
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
07.03.22
-
07.03.23
0.60%
19.03.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
kostojunior 
07.03.22 60%
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.99
17.03.22
-
17.03.23
1.42%
18.03.22

Mori8 
17.03.22 50%
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€80.40
07.01.22
-
07.01.23
-24.19%
13.03.22

Kilianhammernick 
07.01.22 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€19.50
06.01.22
-
06.01.23
-45.13%
13.03.22

Kilianhammernick 
06.01.22 50%
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€531.00
16.10.21
-
16.10.22
-31.56%
13.03.22

Kilianhammernick 
16.10.21 50%
buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€474.50
15.07.21
-
15.07.22
-30.56%
13.03.22

Kilianhammernick 
15.07.21 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.90
02.07.21
-
02.07.22
-20.90%
09.03.22

Innovative
Dependend from some customers or products
Higher risks for its business
ElectricPlayer 
02.07.21 50%
sell
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-21.91%
09.03.22

DirectorDealer 
08.03.21 50%
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-26.29%
09.03.22

DirectorDealer 
08.03.21 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€82.98
08.03.21
-
08.03.22
-72.98%
09.03.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
FXX 
08.03.21 60%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.40
01.03.22
-
01.03.23
2.48%
02.03.22

Mori8 
01.03.22 50%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€57.94
01.03.21
-
01.03.22
-2.93%
02.03.22

DirectorDealer 
01.03.21 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€33.45
05.12.21
€40.00
05.12.22
-27.32%
01.03.22

Could be worthwhile Investment >10% per year
melinda 
05.12.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.22
03.06.21
-
03.06.22
-2.82%
26.02.22

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
Maleri 
03.06.21 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.71
22.02.22
€5.00
22.02.23
18.89%
23.02.22

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
me8 
22.02.22 0%
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€8.98
21.02.21
€10.00
21.02.22
-54.90%
22.02.22

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
kostojunior 
21.02.21 50%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€15.55
21.02.21
-
21.02.22
-25.08%
22.02.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
kostojunior 
21.02.21 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€54.90
15.02.21
€62.00
15.02.22
-4.21%
15.02.22

leolew 
15.02.21 60%
buy
Formycon AG

Start price
Target price
Perf. (%)
€67.20
08.02.21
-
08.02.22
-19.79%
09.02.22

DirectorDealer 
08.02.21 50%
buy
Formycon AG

Start price
Target price
Perf. (%)
€67.40
07.02.21
€80.00
07.02.22
-20.03%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
skatcup 
07.02.21 60%
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.11
05.02.21
€90.00
05.02.22
-5.54%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
mthimm 
05.02.21 80%
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
05.12.21
€57.00
05.12.22
18.68%
03.02.22

Mori8 
05.12.21 50%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.24
01.02.21
€40.00
01.02.22
1.56%
01.02.22

diwin 
01.02.21 50%
buy
MPH Health Care AG

Start price
Target price
Perf. (%)
€26.00
16.05.21
€40.00
16.05.22
-5.77%
29.01.22

Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
jomobb 
16.05.21 90%